NEW YORK, Sept. 1 /PRNewswire/ -- TriMark Publications, LLC (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, cites in its newly published Regenerative Medicine Markets report that the global market for regenerative medicine products will exceed $3 billion in 2010 and is expected to reach $4.5 billion by 2014. Regenerative medicine is a technique to treat injuries and diseases with specially-grown tissues by way of several different methods, including stem cell therapy and tissue engineering.
Before scientific advances such as stem cells, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself (or not) or a surgeon's skilled hands. Now, the area of regenerative medicine promises to revolutionize humanity's ability to remedy countless physical maladies that have afflicted humans and other animals through techniques like stem cells and tissue engineering.
In this study, TriMark Publications reviews the market for regenerative medicine solutions. The areas covered in this study include: available and emerging technologies in the field, the U.S. and global market size for regenerative medicine products, and profiles of companies that are focusing on the regenerative medicine sector.
Reasons to Buy TriMark Content
About TriMark Publications, LLC
TriMark Publications is a global leader in the biotechnology, healthcare and life sciences publishing. For more information, please visit http://www.trimarkpublications.com.
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
|SOURCE TriMark Publications, LLC|
Copyright©2010 PR Newswire.
All rights reserved